Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PRME — Prime Medicine, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,392,887
-$98,197 QoQ
Shares Held
648,479
-9.4% QoQ
Ownership
0.358%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 186 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Derivatives in PRME

reported options exposure · as of Jun 30, 2026
CallValue
$495,198
CallShares
134,200
PutValue
$1,635,039
PutShares
443,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. PRME ranks #77 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,635,039 443,100
2026-06-30 $2,392,887 648,479
2026-06-30 $495,198 134,200
2026-03-31 $650,760 187,000
2026-03-31 $2,491,084 715,829
2026-03-31 $1,555,560 447,000
2025-12-31 $1,636,799 471,700
2025-12-31 $4,083,242 1,176,727
2025-12-31 $227,285 65,500
2025-09-30 $1,489,152 268,800
2025-09-30 $3,237,708 584,424
2025-09-30 $2,213,230 399,500
2025-06-30 $103,493 41,900
2025-06-30 $210,444 85,200
2025-06-30 $1,192,338 482,728
2025-03-31 $42,387 21,300
2025-03-31 $283,811 142,619
2024-12-31 $77,088 26,400
2024-12-31 $108,191 37,052
2024-09-30 $231,813 59,900
2024-09-30 $904,806 233,800
2024-09-30 $445,258 115,054
2024-06-30 $241,580 47,000
2024-06-30 $544,284 105,892
2024-06-30 $272,420 53,000
2024-03-31 $149,184 21,312
2024-03-31 $107,800 15,400
2023-12-31 $108,978 12,300
2023-12-31 $412,743 46,585
2023-06-30 $179,521 12,254